which glp-1 approved for weight loss New Pill Foundayo (Orforglipron) Gets FDA Approval Obesity GLP-1 Medications: Everything You Need
Description
Provenance and peer review: Unsolicited article

By dampening the VTA, GLP-1s subtly influence you to eat less by making it seem less rewarding to eat, even when youre not hungry

Researchers reported 75 ADRD cases among GLP-1 users over a mean follow-up of 2.22 years, compared with 639 ADRD cases among other GLD users over mean follow-up of 3.74 years

J.OrskovC

Costi e accessibilit : non sempre questi farmaci sono facilmente disponibili o economicamente sostenibili

doi:10.1016/S0140-6736(19)31149-3 29